Abemaciclib in Combination With Bicalutamide for Androgen Receptor-positive, HER2-negative Metastatic Breast Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Metastasis
Interventions: DRUG: Abemaciclib|DRUG: Bicalutamide
Sponsor: Icahn School of Medicine at Mount Sinai